Vasculitis in the geriatric population.
Vasculitis represents an uncommon but important group of disease entities that may affect older patients. The most common systemic vasculitic disease in humans is giant cell arteritis, a disease process seen almost exclusively in patients over the age of 50. Vasculitic disease in geriatric patients presents unique challenges with regard to diagnosis and treatment. A thorough understanding of the vasculitic disease entities that may affect older patients as well as their diagnosis and management is essential in minimizing disease and treatment related morbidity and mortality.
Langford
Carol A
CA
Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. langfoc@ccf.org
D000368:Aged; D015267:Churg-Strauss Syndrome / Q000175:diagnosis / Q000503:physiopathology; D015897:Comorbidity; D003449:Cryoglobulinemia / Q000175:diagnosis / Q000628:therapy; D013700:Giant Cell Arteritis / Q000503:physiopathology; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D011695:IgA Vasculitis / Q000175:diagnosis; D010488:Polyarteritis Nodosa / Q000503:physiopathology; D011111:Polymyalgia Rheumatica / Q000503:physiopathology; D014657:Vasculitis / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy